Primera Antena
La primera Antena correspon al debat sobre la perspectiva social a l’avaluació d’innovacions sanitàries, a nivell de medicaments i tecnologies, tractant qüestions com:
- Quina és la mesura adequada de guanys en productivitat?
- Més enllà de la productivitat, què es pot mesurar dins la perspectiva social?
- És a nivell de país, que s’han d’establir les directrius sobre què és rellevant considerar com a guany o cost social, o cal homogeneïtzació de criteris?
- Quin és el panorama internacional en la matèria? Com es podrien adaptar les best practices al sistema d’avaluació espanyol?
Llistat d'articles seleccionats
- The societal perspective in health assessment
- Nurturing societal values in and through health innovations: Comment on" What health system challenges should responsible innovation in health address?"
- Estimating and rewarding the value of healthcare interventions beyond the healthcare sector: a conceptual framework
- The long and winding road towards payment for healthcare innovation with high societal value but limited commercial value: A comparative case study of devices and health information technologies
- How is the societal perspective defined in health technology assessment? Guidelines from around the globe
- HTA243 Guidelines for Incorporating the Societal Perspective and Wider Societal Benefits in Health Technology Assessment
- A review of HTA guidelines on societal and novel value elements
- All health is not equal: the use of modifiers in NICE technology appraisal
- Benefits beyond health in the willingness to pay for a quality-adjusted life-year
- What Does ‘Whole Health’ Really Mean for Health Economics and Outcomes Research?
- Five pillars for societal perspective
- Adoption of a Societal Perspective in Economic Evaluations of Musculoskeletal Disorders: A Conceptual Paper
- Methods for Early Assessment of the Societal Value of Health Technologies: A Scoping Review and Proposal for Classification
- Health economic evaluation of digital nursing technologies: a review of methodological recommendations
- Methodological considerations for estimating indirect costs in children and adolescents with chronic conditions: a scoping review
- Detection of potential causal pathways among social determinants of health: A data-informed framework
- Examining how well economic evaluations capture the value of mental health
- Value is Gendered: The Need for Sex and Gender Considerations in Health Economic Evaluations
- Different attitudes towards estimating indirect costs of disease: The example of cancer
- Taking health economics and outcomes research forward: expanding the definition of value to include whole health
- Assessing the health and welfare benefits of interventions using the Wider Societal Impacts framework
- How innovation can be defined, evaluated and rewarded in health technology assessment
- PD69 Road Map Of Health Equity Considerations In Health Technology Assessments: Identifying The Evidence From Epidemiology To Health Economics
- A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review
- The Health Innovation Impact Checklist: a tool to improve the development and reporting of impact models for global health innovations
- Considering severity in health technology assessment: can we do better?
- Measurement and valuation of the attributes of innovation of healthcare technologies: a systematic review
- The application of social innovation in healthcare: a scoping review
- Striving for a societal perspective: a framework for economic evaluations when costs and effects fall on multiple sectors and decision makers
- Value assessment and decision-making: how to move health systems forward?
- Public spending
- Measurement of productivity
- Routine measurement in low back pain; towards a pragmatic patient-reported productivity cost outcome measurement using the institute for medical technology assessment productivity cost questionnaire
- Moving forward with taking a societal perspective: a themed issue on productivity costs, consumption costs and informal care costs
- Measurement instruments of productivity loss of paid and unpaid work: a systematic review and assessment of suitability for health economic evaluations from a societal perspective
- Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China
- Integrating economic, environmental and societal performance within the productivity measurement
- Associating health-related quality-of-life score with time uses to inform productivity measures in cost-effectiveness analysis
- Systematic literature review of the use of productivity losses/gains in cost-effectiveness analyses of immune-mediated disorders
- Measuring, analyzing, and presenting work productivity loss in randomized controlled trials: a scoping review
- Societal return and public health impact
- Integration of Social Return on Investment with Health Impact Assessment and evaluation frameworks
- Capturing the social value and return on investment of public health services and interventions
- Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework
- Presenting a social value database and simulator for public health
- Merits of the social return on investment methodology for assessing the value of palliative care programmes
- Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts
- The development of the concept of return-on-investment from large-scale quality improvement programmes in healthcare: an integrative systematic literature review
- Analyses of the return on investment of public health 7 interventions: a scoping review and recommendations for future studies
- Balancing clinical benefit and social value: challenges in HTA assessments
- Real-world effectiveness vs. clinical trial results
- Use of Real-World Evidence in Health Technology Reassessments Across Six Health Technology Assessment Agencies
- Health technology assessment for in silico medicine: social, ethical and legal aspects
- Real-world evidence to reinforce clinical trial evidence in health technology assessment: a critical review of real-world evidence requirements from seven countries and recommendations to improve acceptance
- Spillover effects on family and caregivers
- Food for thought: more explicit guidance for inclusion of caregiver perspectives in health technology assessment
- Development of stakeholder-informed recommendations for inclusion of family spillover effects in health technology assessment
- Indirect costs of Alzheimer’s disease: unpaid caregiver burden and patient productivity loss
- Addressing the distributional consequences of spillovers in health economic evaluation: A prioritarian approach
- Recommendations for emerging good practice and future research in relation to family and caregiver health spillovers in health economic 8 evaluations: a report of the SHEER task force
- Including carer health-related quality of life in NICE health technology assessments in the United Kingdom
- A systematic review of methods and practice for integrating maternal, fetal, and child health outcomes, and family spillover effects into cost-utility analyses
- Family spillover effects: are economic evaluations misrepresenting the value of healthcare interventions to society?
- Toward a broader concept of societal value: family spillovers in Alzheimer's disease
- Carers’ health-related quality of life in global health technology assessment: guidance, case studies and recommendations
- Systematic review of cost-utility analyses that have included carer and family member health-related quality of life
- Environmental impact
- Main challenges of incorporating environmental impacts in the economic evaluation of health technology assessment: a scoping review
- Incorporating carbon into health care: adding carbon emissions to health technology assessments
- Assessing the social and environmental impact of healthcare technologies: Towards an extended social return on investment
- Incorporating environmental and sustainability considerations into health technology assessment and clinical and public health guidelines: a scoping review
- Environmental impact assessment in health technology assessment: principles, approaches, and challenges
- How can environmental impacts be incorporated in health technology assessment, and how impactful would this be?
- Methods to include environmental impacts in health economic evaluations and health technology assessments: a scoping review
- International landscape and current practices
- The evolving nature of Health Technology Assessment: A critical appraisal of NICE’s new methods manual
- Meta-analysis of economic evaluation studies: data harmonisation and methodological issues
- Good practices for health technology assessment guideline development: a report of the Health Technology Assessment International, HTAsiaLink, and ISPOR special task force
- A call to action to harmonize patient-reported outcomes evidence requirements across key European HTA bodies in oncology
- HTA302 Consideration of Societal and Equity-Based Value Attributes (VAs) by the National Institute for Health and Care Excellence (NICE) During Evaluation of Innovative Technologies in 2023
- Implementing the EU HTA Regulation: Insights from semi-structured interviews on patient expectations, Belgian and European institutional perspectives, and industry outlooks
- Challenges of health technology assessment in pluralistic healthcare systems: an ISPOR Council Report
- Harmonizing HTA evidence needs and expectations: challenges and opportunities to improve evidence generation, ensure access and affordability
- Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations: a scoping review
- Towards a European harmonization of health technology assessment recommendations executive paper of European regulatory conference focused on the EU commission proposal to harmonize HTA
- Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
- The current landscape of HTA framework and key challenges
- Algorithms and heuristics of health technology assessments: a retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries
- Including carer health-related quality of life in NICE health technology assessments in the United Kingdom
- Expanding health technology assessment towards broader value: Ireland as a case study
- EE4 Should NICE Consider Adoption of a Societal Perspective? Comparison of the ICER 2023 Value Assessment Framework with the NICE 2022 Methods Guide
- Public value and digital health: The example of guiding values in the national digital health strategy of France
- What is needed to successfully implement the EU HTA Regulation enabling broad patient access in Europe
- Health Technology Assessment (HTA) Using MAFEIP (Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing)
- The development of a new approach for the harmonized multi-sectoral and multi-country cost valuation of services: the PECUNIA reference unit cost (RUC) templates
- Factors influencing the institutionalization of health technology assessment: a scoping literature review
- Multistakeholder perceptions of additional value elements for United States value assessment of health interventions
- Societal Versus Healthcare Perspectives on the Cost Effectiveness of Ocrelizumab for Treatment of Primary Progressive Multiple Sclerosis in Aotearoa New Zealand
- Institutional Country-Specific Context and Value Drivers in Health Technology Assessment: A European Perspective
- Challenges and reforms in Spain’s health technology assessment system: analysis of criteria influencing medicines’ reimbursement decisions between 2019 and 2022 in Spain
- Mapping methods gaps between EU joint clinical assessments and local health technology assessment decision-making: an environmental scan of guidance in select EU markets and harmonization challenges
- EU HTA regulation and joint clinical assessment—threat or opportunity?
- Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices
- Methodological advancements in costing methods for (public) health economic evaluations: results from the European PECUNIA project
- An overview of the perspectives used in health economic evaluations
- OD14 Harmonization Of HTA For Digital Health Technologies: The EU-Funded European Digital Health Technology Assessment Project
- Ensuring the Efficiency and Effectiveness of Joint Clinical Assessment in National HTA Decision-Making: Insights from the 2024 CIRS Multi-Stakeholder Workshop